{"id":3662,"date":"2016-09-14T09:50:07","date_gmt":"2016-09-14T12:50:07","guid":{"rendered":"https:\/\/prodoctor.net\/blog\/?p=3662"},"modified":"2021-06-10T12:01:31","modified_gmt":"2021-06-10T15:01:31","slug":"pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos","status":"publish","type":"post","link":"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/","title":{"rendered":"Pacientes com Esclerose M\u00faltipla ganham op\u00e7\u00f5es nos gen\u00e9ricos"},"content":{"rendered":"<p>O registro de medicamentos <strong>gen\u00e9ricos tem proporcionado<\/strong> n\u00e3o apenas alternativas para os consumidores, mas tamb\u00e9m uma economia, uma vez que chegam ao mercado com <strong>um valor 35% menor<\/strong> que o pre\u00e7o de tabela dos de refer\u00eancia.<\/p>\n<p>Na \u00faltima segunda-feira (12\/09) , a Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) publicou no Di\u00e1rio Oficial da Uni\u00e3o (DOU) o registro do <strong>cloridrato de fingolimode<\/strong> c\u00e1psula dura, droga que pode alterar a forma que o<strong> sistema imune do corpo funciona<\/strong>, auxiliando a combater os danos nos nervos causados pela Esclerose M\u00faltipla (EM).<\/p>\n<p>Com isso, <strong>tanto os pacientes quanto os m\u00e9dicos<\/strong> ganham uma alternativa de menor custo para o tratamento da Esclerose M\u00faltipla remitente recorrente. A Associa\u00e7\u00e3o Brasileira de Esclerose M\u00faltipla (ABEM) estima que atualmente a enfermidade <strong>atinge 35 mil brasileiros<\/strong>.<\/p>\n<p>Sem cura, pode <strong>apresentar uma variada sintomatologia<\/strong>, como por exemplo: fadiga intensa, depress\u00e3o, fraqueza muscular, altera\u00e7\u00e3o do equil\u00edbrio da coordena\u00e7\u00e3o motora, dores articulares e disfun\u00e7\u00e3o intestinal e da bexiga.<\/p>\n<p>A Esclerose M\u00faltipla \u00e9 uma doen\u00e7a neurol\u00f3gica, cr\u00f4nica e autoimune, com as c\u00e9lulas de defesa do organismo <strong>atacando o pr\u00f3prio sistema nervoso central<\/strong> e provocando les\u00f5es cerebrais e medulares.<\/p>\n<p>As causas da doen\u00e7a <strong>ainda s\u00e3o desconhecidas<\/strong> atingindo em sua maioria as pessoas jovens, especialmente as mulheres de 20 a 40 anos. Os sinais e sintomas n\u00e3o podem ser explicados por uma \u00fanica les\u00e3o e o seu curso cl\u00ednico \u00e9 caracterizado mais frequentemente por surtos, seguidos de per\u00edodos de remiss\u00f5es.<\/p>\n<p>A Esclerose M\u00faltipla n\u00e3o \u00e9 fatal e, com os constantes e aprofundados estudos, muitos <strong>pacientes t\u00eam conseguido levar uma vida normal<\/strong>. Hoje, j\u00e1 se sabe sobre a imunologia da enfermidade, possibilitando a<strong> descoberta de medicamentos<\/strong> para controlar sua evolu\u00e7\u00e3o.<\/p>\n<p>No ano passado, a Anvisa concedeu o registro a um medicamento oral para tratar pacientes adultos com Esclerose M\u00faltipla recorrente remitente.<\/p>\n<p><strong>O Tecfidera<\/strong> (fumarato de dimetila), da empresa Biogen, j\u00e1 \u00e9 comercializado nos Estados Unidos, Canad\u00e1, Austr\u00e1lia e Uni\u00e3o Europeia. No mercado americano, em poucos meses de comercializa\u00e7\u00e3o, a droga tornou-se a <strong>terapia mais prescrita<\/strong> para o tratamento da enfermidade.<\/p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>O registro de medicamentos gen\u00e9ricos tem proporcionado n\u00e3o apenas alternativas para os consumidores, mas tamb\u00e9m uma economia, uma vez&#8230;<\/p>\n","protected":false},"author":3,"featured_media":19522,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"footnotes":""},"categories":[415,413],"tags":[],"class_list":["post-3662","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicamentos-e-farmacia","category-medicina-e-saude"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pacientes com Esclerose M\u00faltipla ganham op\u00e7\u00f5es nos gen\u00e9ricos<\/title>\n<meta name=\"description\" content=\"Registro do cloridrato de fingolimode, c\u00e1psula dura, amplia as op\u00e7\u00f5es de tratamento da esclerose m\u00faltipla recorrente e reduz o pre\u00e7o para o paciente.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pacientes com Esclerose M\u00faltipla ganham op\u00e7\u00f5es nos gen\u00e9ricos\" \/>\n<meta property=\"og:description\" content=\"Registro do cloridrato de fingolimode, c\u00e1psula dura, amplia as op\u00e7\u00f5es de tratamento da esclerose m\u00faltipla recorrente e reduz o pre\u00e7o para o paciente.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog ProDoctor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/prodoctorsoftware\" \/>\n<meta property=\"article:published_time\" content=\"2016-09-14T12:50:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-10T15:01:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/09\/esclerose-multipla-min.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"770\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Simara Laura Salgado\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@prodoctorsoft\" \/>\n<meta name=\"twitter:site\" content=\"@prodoctorsoft\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Simara Laura Salgado\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/\"},\"author\":{\"name\":\"Simara Laura Salgado\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/390a2585fd9ba0e7315724b234e96158\"},\"headline\":\"Pacientes com Esclerose M\u00faltipla ganham op\u00e7\u00f5es nos gen\u00e9ricos\",\"datePublished\":\"2016-09-14T12:50:07+00:00\",\"dateModified\":\"2021-06-10T15:01:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/\"},\"wordCount\":377,\"publisher\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/09\/esclerose-multipla-min.jpg\",\"articleSection\":[\"Medicamentos e Farm\u00e1cia\",\"Medicina e Sa\u00fade\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/\",\"url\":\"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/\",\"name\":\"Pacientes com Esclerose M\u00faltipla ganham op\u00e7\u00f5es nos gen\u00e9ricos\",\"isPartOf\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/09\/esclerose-multipla-min.jpg\",\"datePublished\":\"2016-09-14T12:50:07+00:00\",\"dateModified\":\"2021-06-10T15:01:31+00:00\",\"description\":\"Registro do cloridrato de fingolimode, c\u00e1psula dura, amplia as op\u00e7\u00f5es de tratamento da esclerose m\u00faltipla recorrente e reduz o pre\u00e7o para o paciente.\",\"breadcrumb\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/#primaryimage\",\"url\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/09\/esclerose-multipla-min.jpg\",\"contentUrl\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/09\/esclerose-multipla-min.jpg\",\"width\":770,\"height\":400},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/prodoctor.net\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pacientes com Esclerose M\u00faltipla ganham op\u00e7\u00f5es nos gen\u00e9ricos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#website\",\"url\":\"https:\/\/prodoctor.net\/blog\/\",\"name\":\"Blog ProDoctor\",\"description\":\"Tudo sobre o mundo da Sa\u00fade\",\"publisher\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/prodoctor.net\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#organization\",\"name\":\"ProDoctor Software S\/A\",\"url\":\"https:\/\/prodoctor.net\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/01\/Logo_PDo_Lateral.png\",\"contentUrl\":\"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/01\/Logo_PDo_Lateral.png\",\"width\":2014,\"height\":485,\"caption\":\"ProDoctor Software S\/A\"},\"image\":{\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/prodoctorsoftware\",\"https:\/\/x.com\/prodoctorsoft\",\"https:\/\/www.instagram.com\/prodoctorsoftware\/\",\"https:\/\/www.linkedin.com\/company\/prodoctor-software-ltda\",\"https:\/\/www.youtube.com\/channel\/UCIWuDLsVtIpX-PEqQn1pNlw\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/390a2585fd9ba0e7315724b234e96158\",\"name\":\"Simara Laura Salgado\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f7d63fa9b2bc65a160e3d167e24d749aab83b89ad07013427cd4a27939cc0043?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f7d63fa9b2bc65a160e3d167e24d749aab83b89ad07013427cd4a27939cc0043?s=96&d=mm&r=g\",\"caption\":\"Simara Laura Salgado\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pacientes com Esclerose M\u00faltipla ganham op\u00e7\u00f5es nos gen\u00e9ricos","description":"Registro do cloridrato de fingolimode, c\u00e1psula dura, amplia as op\u00e7\u00f5es de tratamento da esclerose m\u00faltipla recorrente e reduz o pre\u00e7o para o paciente.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/","og_locale":"pt_BR","og_type":"article","og_title":"Pacientes com Esclerose M\u00faltipla ganham op\u00e7\u00f5es nos gen\u00e9ricos","og_description":"Registro do cloridrato de fingolimode, c\u00e1psula dura, amplia as op\u00e7\u00f5es de tratamento da esclerose m\u00faltipla recorrente e reduz o pre\u00e7o para o paciente.","og_url":"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/","og_site_name":"Blog ProDoctor","article_publisher":"https:\/\/www.facebook.com\/prodoctorsoftware","article_published_time":"2016-09-14T12:50:07+00:00","article_modified_time":"2021-06-10T15:01:31+00:00","og_image":[{"width":770,"height":400,"url":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/09\/esclerose-multipla-min.jpg","type":"image\/jpeg"}],"author":"Simara Laura Salgado","twitter_card":"summary_large_image","twitter_creator":"@prodoctorsoft","twitter_site":"@prodoctorsoft","twitter_misc":{"Escrito por":"Simara Laura Salgado","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/#article","isPartOf":{"@id":"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/"},"author":{"name":"Simara Laura Salgado","@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/390a2585fd9ba0e7315724b234e96158"},"headline":"Pacientes com Esclerose M\u00faltipla ganham op\u00e7\u00f5es nos gen\u00e9ricos","datePublished":"2016-09-14T12:50:07+00:00","dateModified":"2021-06-10T15:01:31+00:00","mainEntityOfPage":{"@id":"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/"},"wordCount":377,"publisher":{"@id":"https:\/\/prodoctor.net\/blog\/#organization"},"image":{"@id":"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/#primaryimage"},"thumbnailUrl":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/09\/esclerose-multipla-min.jpg","articleSection":["Medicamentos e Farm\u00e1cia","Medicina e Sa\u00fade"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/","url":"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/","name":"Pacientes com Esclerose M\u00faltipla ganham op\u00e7\u00f5es nos gen\u00e9ricos","isPartOf":{"@id":"https:\/\/prodoctor.net\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/#primaryimage"},"image":{"@id":"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/#primaryimage"},"thumbnailUrl":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/09\/esclerose-multipla-min.jpg","datePublished":"2016-09-14T12:50:07+00:00","dateModified":"2021-06-10T15:01:31+00:00","description":"Registro do cloridrato de fingolimode, c\u00e1psula dura, amplia as op\u00e7\u00f5es de tratamento da esclerose m\u00faltipla recorrente e reduz o pre\u00e7o para o paciente.","breadcrumb":{"@id":"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/#primaryimage","url":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/09\/esclerose-multipla-min.jpg","contentUrl":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/09\/esclerose-multipla-min.jpg","width":770,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/prodoctor.net\/blog\/pacientes-com-esclerose-multipla-ganham-opcoes-nos-genericos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/prodoctor.net\/blog\/"},{"@type":"ListItem","position":2,"name":"Pacientes com Esclerose M\u00faltipla ganham op\u00e7\u00f5es nos gen\u00e9ricos"}]},{"@type":"WebSite","@id":"https:\/\/prodoctor.net\/blog\/#website","url":"https:\/\/prodoctor.net\/blog\/","name":"Blog ProDoctor","description":"Tudo sobre o mundo da Sa\u00fade","publisher":{"@id":"https:\/\/prodoctor.net\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/prodoctor.net\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/prodoctor.net\/blog\/#organization","name":"ProDoctor Software S\/A","url":"https:\/\/prodoctor.net\/blog\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/01\/Logo_PDo_Lateral.png","contentUrl":"https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2017\/01\/Logo_PDo_Lateral.png","width":2014,"height":485,"caption":"ProDoctor Software S\/A"},"image":{"@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/prodoctorsoftware","https:\/\/x.com\/prodoctorsoft","https:\/\/www.instagram.com\/prodoctorsoftware\/","https:\/\/www.linkedin.com\/company\/prodoctor-software-ltda","https:\/\/www.youtube.com\/channel\/UCIWuDLsVtIpX-PEqQn1pNlw"]},{"@type":"Person","@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/390a2585fd9ba0e7315724b234e96158","name":"Simara Laura Salgado","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/prodoctor.net\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f7d63fa9b2bc65a160e3d167e24d749aab83b89ad07013427cd4a27939cc0043?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f7d63fa9b2bc65a160e3d167e24d749aab83b89ad07013427cd4a27939cc0043?s=96&d=mm&r=g","caption":"Simara Laura Salgado"}}]}},"taxonomy_info":{"category":[{"value":415,"label":"Medicamentos e Farm\u00e1cia"},{"value":413,"label":"Medicina e Sa\u00fade"}]},"featured_image_src_large":["https:\/\/prodoctor.net\/blog\/wp-content\/uploads\/2016\/09\/esclerose-multipla-min.jpg",770,400,false],"author_info":{"display_name":"Simara Laura Salgado","author_link":"https:\/\/prodoctor.net\/blog\/author\/simara-laura\/"},"comment_info":0,"category_info":[{"term_id":415,"name":"Medicamentos e Farm\u00e1cia","slug":"medicamentos-e-farmacia","term_group":0,"term_taxonomy_id":415,"taxonomy":"category","description":"","parent":0,"count":132,"filter":"raw","cat_ID":415,"category_count":132,"category_description":"","cat_name":"Medicamentos e Farm\u00e1cia","category_nicename":"medicamentos-e-farmacia","category_parent":0},{"term_id":413,"name":"Medicina e Sa\u00fade","slug":"medicina-e-saude","term_group":0,"term_taxonomy_id":413,"taxonomy":"category","description":"","parent":0,"count":149,"filter":"raw","cat_ID":413,"category_count":149,"category_description":"","cat_name":"Medicina e Sa\u00fade","category_nicename":"medicina-e-saude","category_parent":0}],"tag_info":false,"_links":{"self":[{"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/posts\/3662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/comments?post=3662"}],"version-history":[{"count":7,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/posts\/3662\/revisions"}],"predecessor-version":[{"id":19523,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/posts\/3662\/revisions\/19523"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/media\/19522"}],"wp:attachment":[{"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/media?parent=3662"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/categories?post=3662"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prodoctor.net\/blog\/wp-json\/wp\/v2\/tags?post=3662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}